Is the Medibank share price a buy following the ASX 200 insurer's latest update?

Does Medibank's update make it a buy or not?

| More on:
Two healthcare workers, a male doctor in the background with a woman in scrubs in the foreground,, smile towards the camera against a plain backdrop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MP1) share price is edging lower on Tuesday.

In afternoon trade, the private health insurer's shares are down slightly to $3.50.

What's going on with the Medibank share price?

The Medibank share price is edging lower today after investors gave a lukewarm response to the company's market update.

According to the release, industry growth remains strong with a continuation of factors supporting participation.

However, Medibank has only reported financial year to date private health insurance policyholder growth of 0.4k policyholders or 0.02% as of 31 March. This compares to its previous guidance of 0.5% to 0.75% growth in FY 2023. Though, it does expect a strong fourth quarter and positive momentum leading into FY 2024.

The company also expects to announce a further customer give back before the end of the quarter, which is great for policyholders but perhaps not for its bottom line and dividends.

In addition, the company advised that it no longer expects its non-resident business gross profit "to be higher" than the first half, where it reported growth of 106.7%. It now expects gross profit to be "approximately double from FY22."

Should you buy shares?

While the broker community hasn't had chance to respond to this latest update, as things stand, they aren't urging investors to buy the company's shares.

For example, the likes of Citi, Macquarie, Morgan Stanley, and Morgans all have the equivalent of hold ratings and price targets a touch lower than where the Medibank share price currently trades.

Citi explained why it is sitting on the fence with this one:

Medibank's return to policyholder growth in February and its confidence that the initial cybercrime impacts on its business have started to subside suggest that the previous allowance we had in our forecasts for continued p/h losses over the next 18 months is too conservative. So, we adjust our growth forecasts accordingly.

There will, however, likely be ongoing cyberattack impacts suggesting the stock is still not without risk. These include potential class actions, etc. Our EPS changes which also allow for higher investment yields are FY23E: +7%; FY24E: +11%; FY25E: +13%. We retain our Neutral call lifting our TP to A$3.45, with this now set at a ~5% (was ~8%) discount to our valuation to account for the continued, but lower, cyberattack risk.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

ASX 200 healthcare stock rockets on $75 million news

This marks another positive step for the company.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

CSL shares are in the red for 2024. Are they a buy?

Meanwhile, the broader market has extended to new highs this year.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Market News

Guess which ASX 300 stock is jumping 11% on big news

Big news is giving this stock an even bigger lift on Tuesday. What's happening?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 200 healthcare stock is starting the week with a bang on big news!

What is getting investors excited today? Let's find out.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

'Trading at a discount': Why now is the time to buy CSL shares

This investing expert says CSL shares now represent an appealing buying opportunity.

Read more »